Measurable residual disease-driven treatment in first-line chronic lymphocytic leukaemia. Davids MS, Lin KH, Mohamed AI, Munir T, et al. Br J Haematol 2025;206:33-43.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Davids MS, Lin KH, Mohamed AI, Munir T, et al. Measurable residual disease-driven treatment in first-line chronic lymphocytic leukaemia. Br J Haematol 2025;206:33-43.
PMID: 39538975